Literature DB >> 8633842

Renal impairment associated with losartan.

D R Saine, E R Ahrens.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8633842     DOI: 10.7326/0003-4819-124-8-199604150-00015

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  6 in total

Review 1.  Comparative safety and tolerability of angiotensin II receptor antagonists.

Authors:  L Mazzolai; M Burnier
Journal:  Drug Saf       Date:  1999-07       Impact factor: 5.606

2.  Structural insights into central hypertension regulation by human aminopeptidase A.

Authors:  Yang Yang; Chang Liu; Yi-Lun Lin; Fang Li
Journal:  J Biol Chem       Date:  2013-07-25       Impact factor: 5.157

3.  Brain renin-angiotensin system blockade by systemically active aminopeptidase A inhibitors: a potential treatment of salt-dependent hypertension.

Authors:  Marie-Claude Fournie-Zaluski; Celine Fassot; Bruno Valentin; Dragan Djordjijevic; Annabelle Reaux-Le Goazigo; Pierre Corvol; Bernard P Roques; Catherine Llorens-Cortes
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-10       Impact factor: 11.205

Review 4.  Aminopeptidase A inhibitors as centrally acting antihypertensive agents.

Authors:  Laurence Bodineau; Alain Frugière; Yannick Marc; Cédric Claperon; Catherine Llorens-Cortes
Journal:  Heart Fail Rev       Date:  2008-01-03       Impact factor: 4.214

5.  Reversible renal impairment induced by treatment with the angiotensin II receptor antagonist candesartan in a patient with bilateral renal artery stenosis.

Authors:  T L Johansen; A Kjaer
Journal:  BMC Nephrol       Date:  2001-05-17       Impact factor: 2.388

Review 6.  Angiotensin II receptor antagonists. Potential in elderly patients with cardiovascular disease.

Authors:  L M Burrell; C I Johnston
Journal:  Drugs Aging       Date:  1997-06       Impact factor: 4.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.